Yes. QbCheck supports fully remote testing through the secure QbPath patient portal. Patients can complete tests on Mac or Windows laptops with guided video and text instructions. 

Yes, QbCheck test works offline as well as online. However, the internet is required during the test set-up and after the test to send the results.  

Both in-person and remote tests start in QbClinic. 

• For in-clinic tests: clinicians can generate a unique voucher and launch instantly 

• For remote tests: clinicians send a unique URL to the patient and track their progress centrally 

This ensures consistent governance across both settings, so patients and clinicians have the flexibility to choose the method that best fits their needs. 

QbCheck delivers visual, easy-to-interpret reports that are simple to understand. Reports include recorded ability test scores, optional Qbtech rating scales, and retest comparison reports to track treatment response over time. 

Yes. QbCheck is an FDA & MDR-cleared and CE-marked ADHD diagnosis and treatment platform. Data is securely managed in compliance with clinical governance standards, ensuring patient privacy and defensible clinical practice.  

You can make initial corrections, but once the patient validates their details, they are locked and cannot be changed.   

QbCheck provides comprehensive resources through the QbClinic portal, including user guides, training videos, and customer and tech support. Additional resources like patient psychoeducation guides may also be provided, on request.  

You can view clinical resources for the US here. Alternatively, you can view clinical resources for the UK here.

Yes. QbCheck is designed for clinics of all sizes, including multi-site operations. Our QbClinic portal helps with multi-clinic management, configurable user roles, and progress tracking across locations. It ensures consistent workflows and streamlines administration workload for large or growing practices. You can read more about ADHD care in telehealth here. 

QbCheck offers bundled packages, subscription models and custom packages to suit all kinds of needs and clinics of all sizes. Flexible options make it easy to scale ADHD assessment services while controlling costs.

Unlike gamified or non-regulated alternatives, QbCheck is FDA & MDR-cleared, CE-marked, and backed by extensive peer-reviewed research. Our tests are also the only ones that can measure hyperactivity, a core ADHD symptom, down to 1mm accuracy. 

Qbtech’s objective ADHD technology is currently available in 18 countries and has over 1 million test takers globally. Our international presence ensures regulatory alignment (FDA/MDR/CE/MRHA), robust data governance, and dependable support across regions. For details, read our manifesto. 

These countries include US, UK, Australia, Austria, Belgium, Denmark, Estonia, Ireland, Finland, Germany, Liechtenstein, Malta, Netherlands, New Zealand, Norway, Switzerland and Sweden.